Influence of B cells in liver fibrosis associated with hepatitis B virus harboring basal core promoter mutations

Journal of Medical Virology

Volumn 84, Issue 12, 2012, Pages 1889-1896

  Mohamadkhani, Ashraf ^a   Bastani, Faegh ^b   Sotoudeh, Masoud ^a   Sayehmiri, Kourosh ^c   Shahnazari, Parisa ^d   Montazeri, Ghodratollah ^a   Poustchi, Hossein ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TABRIZ   (Iran)

^c ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d AVICENNA RESEARCH INSTITUTE   (Iran)

Author keywords

A proliferation inducing ligand (APRIL); B lymphocyte; Chronic hepatitis B; IgD

Indexed keywords

APRIL PROTEIN; IMMUNOGLOBULIN D; VIRUS DNA;

ADULT; ARTICLE; B LYMPHOCYTE; BASAL CORE PROMOTER MUTATION; BLOOD ANALYSIS; CONTROLLED STUDY; DNA SEQUENCE; ENZYME IMMUNOASSAY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER FIBROSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION;

ADULT; B-LYMPHOCYTES; BIOPSY; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOME, VIRAL; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MUTATION; PROMOTER REGIONS, GENETIC; RECEPTORS, FC; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 84867722840     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23410     Document Type: Article

References (34)

1. Bahri O, Cheikh I, Hajji N, Djebbi A, Maamouri N, Sadraoui A, Mami NB, Triki H. 2006. Hepatitis B genotypes, precore and core promoter mutants circulating in Tunisia. J Med Virol 78: 353-357.
2. Belnoue E, Pihlgren M, McGaha TL, Tougne C, Rochat AF, Bossen C, Schneider P, Huard B, Lambert PH, Siegrist CA. 2008. APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Blood 111: 2755-2764.
3. Bhogal RK, Bona CA. 2005. B cells: No longer bystanders in liver fibrosis. J Clin Invest 115: 2962-2965.
4. Blackberg J, Kidd-Ljunggren K. 2003. Mutations within the hepatitis B virus genome among chronic hepatitis B patients with hepatocellular carcinoma. J Med Virol 71: 18-23.
5. Bossen C, Cachero TG, Tardivel A, Ingold K, Willen L, Dobles M, Scott ML, Maquelin A, Belnoue E, Siegrist CA, Chevrier S, Acha-Orbea H, Leung H, Mackay F, Tschopp J, Schneider P. 2008. TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts. Blood 111: 1004-1012.
6. Castigli E, Wilson SA, Scott S, Dedeoglu F, Xu S, Lam KP, Bram RJ, Jabara H, Geha RS. 2005. TACI and BAFF-R mediate isotype switching in B cells. J Exp Med 201: 35-39.
7. Chang JJ, Lewin SR. 2007. Immunopathogenesis of hepatitis B virus infection. Immunol Cell Biol 85: 16-23.
8. Gan RB, Chu MJ, Shen LP, Qian SW, Li ZP. 1987. The complete nucleotide sequence of the cloned DNA of hepatitis B virus subtype adr in pADR-1. Sci Sin [B] 30: 507-521.
9. Hardy RR, Li YS, Allman D, Asano M, Gui M, Hayakawa K. 2000. B-cell commitment, development and selection. Immunol Rev 175: 23-32.
10. He B, Xu W, Santini PA, Polydorides AD, Chiu A, Estrella J, Shan M, Chadburn A, Villanacci V, Plebani A, Knowles DM, Rescigno M, Cerutti A. 2007. Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity 26: 812-826.
11. Inman CF, Murray TZ, Bailey M, Cose S. 2011. Most B cells in non-lymphoid tissues are naive. Immunol Cell Biol 90: 235-242.
12. Ishaka K, Baptistab A, Bianchic L, Callead F, Grootee JD, Gudatf F. 1995. Histological grading and staging of chronic hepatitis. J Hepatology 22: 696-699.
13. Kim KM, Reth M. 1995. The B cell antigen receptor of class IgD induces a stronger and more prolonged protein tyrosine phosphorylation than that of class IgM. J Exp Med 181: 1005-1014.
14. Kimberley FC, Hahne M, Medema JP. 2009. "APRIL hath put a spring of youth in everything": Relevance of APRIL for survival. J Cell Physiol 218: 1-8.
15. Koelsch K, Zheng NY, Zhang Q, Duty A, Helms C, Mathias MD, Jared M, Smith K, Capra JD, Wilson PC. 2007. Mature B cells class switched to IgD are autoreactive in healthy individuals. J Clin Invest 117: 1558-1565.
16. Lutz C, Ledermann B, Kosco-Vilbois MH, Ochsenbein AF, Zinkernagel RM, Kohler G, Brombacher F. 1998. IgD can largely substitute for loss of IgM function in B cells. Nature 393: 797-801.
17. Maini MK, Bertoletti A. 2000. How can the cellular immune response control hepatitis B virus replication? J Viral Hepat 7: 321-326.
18. Michel ML, Malmassari SL, Deng Q, Fontaine H, Houitte D, Rimlinger F, Thiers V, Maillere B, Pol S. 2007. Impact of hepatitis B virus basic core promoter mutations on T cell response to an immunodominant HBx-derived epitope. Hepatology 45: 1199-1209.
19. Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, Damavand B, Azimzadeh P, Derakhshan F, Sabahi F, Zali MR. 2012. Characterization of hepatitis B virus genome variability in Iranian patients with chronic infection, a nationwide study. J Med Virol 84: 414-423.
20. Montazeri G. 2006. Current treatment of chronic hepatitis B. Arch Iran Med 9: 1-10.
21. Novobrantseva TI, Majeau GR, Amatucci A, Kogan S, Brenner I, Casola S, Shlomchik MJ, Koteliansky V, Hochman PS, Ibraghimov A. 2005. Attenuated liver fibrosis in the absence of B cells. J Clin Invest 115: 3072-3082.
22. Oliviero B, Cerino A, Varchetta S, Paudice E, Pai S, Ludovisi S, Zaramella M, Michelone G, Pugnale P, Negro F, Barnaba V, Mondelli MU. 2010. Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections. J Hepatol 55: 53-60.
23. Poustchi H, Mohamadkhani A, Bowden S, Montazeri G, Ayres A, Revill P, Farrell GC, Locarnini S, George J, Malekzadeh R. 2008. Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease. J Viral Hepat 15: 753-760.
24. Sprengers D, van der Molen RG, Kusters JG, Hansen B, Niesters HG, Schalm SW, Janssen HL. 2006. Different composition of intrahepatic lymphocytes in the immune-tolerance and immune-clearance phase of chronic hepatitis B. J Med Virol 78: 561-568.
25. Stavnezer J, Amemiya CT. 2004. Evolution of isotype switching. Semin Immunol 16: 257-275.
26. Stein JV, Lopez-Fraga M, Elustondo FA, Carvalho-Pinto CE, Rodriguez D, Gomez-Caro R, De Jong J, Martinez AC, Medema JP, Hahne M. 2002. APRIL modulates B and T cell immunity. J Clin Invest 109: 1587-1598.
27. Stemler M, Weimer T, Tu ZX, Wan DF, Levrero M, Jung C, Pape GR, Will H. 1990. Mapping of B-cell epitopes of the human hepatitis B virus X protein. J Virol 64: 2802-2809.
28. Sun B, Karin M. 2008. NF-kappaB signaling, liver disease and hepatoprotective agents. Oncogene 27: 6228-6244.
29. Sunami Y, Leithauser F, Gul S, Fiedler K, Guldiken N, Espenlaub S, Holzmann KH, Hipp N, Sindrilaru A, Luedde T, Baumann B, Wissel S, Kreppel F, Schneider M, Scharffetter-Kochanek K, Kochanek S, Strnad P, Wirth T. 2012. Hepatic activation of IKK/NF-kappaB signaling induces liver fibrosis via macrophage-mediated chronic inflammation. Hepatology 56: 1117-1128.
30. Tanaka Y, Kanai F, Kawakami T, Tateishi K, Ijichi H, Kawabe T, Arakawa Y, Nishimura T, Shirakata Y, Koike K, Omata M. 2004. Interaction of the hepatitis B virus X protein (HBx) with heat shock protein 60 enhances HBx-mediated apoptosis. Biochem Biophys Res Commun 318: 461-469.
31. Tsai TH, Huang CF, Wei JC, Ho MS, Wang L, Tsai WY, Lin CC, Xu FL, Yang CC. 2006. Study of IgG subclass profiles of anti-HBs in populations with different HBV infection status. Viral Immunol 19: 277-284.
32. Vitetta ES, Uhr JW. 1976. Cell surface immunoglobulin. XIX. Susceptibility of IgD and IgM on murine splenocytes to cleavage by papain. J Immunol 117: 1579-1583.
33. Xiao Y, Motomura S, Podack ER. 2008. APRIL (TNFSF13) regulates collagen-induced arthritis, IL-17 production and Th2 response. Eur J Immunol 38: 3450-3458.
34. Zheng Y, Li J, Ou JH. 2004. Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein. J Virol 78: 6908-6914.